Radiation Oncology/Therapy: Page 210

Elekta launches updated version of Monaco
By AuntMinnie.com staff writers
Radiation oncology firm Elekta announced it has released a new version of its Monaco treatment planning system.
September 18, 2012
ASCO BSC: Long-term APBI outcomes are favorable
By Cynthia E. Keen
Long-term outcomes of breast cancer patients participating in a clinical trial evaluating the effectiveness of accelerated partial-breast irradiation (APBI) continue to be favorable, according to a presentation in San Francisco last week at the American Society of Clinical Oncology's (ASCO) Breast Cancer Symposium (BCS).
September 18, 2012
RaySearch lands RayStation order
By AuntMinnie.com staff writers
Radiation therapy firm RaySearch has receive an order from First Coast Oncology in Jacksonville, FL.
September 17, 2012
Exploiting log files for optimal radiotherapy QA
By Tami Freeman
Quality assurance (QA) of intensity-modulated radiation therapy (IMRT) is a vital component in the radiotherapy process, but current QA procedures are far from optimal. Log files produced by radiotherapy systems can be exploited to vastly improve IMRT quality assurance.
September 17, 2012
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Elekta adds Australian customer
By AuntMinnie.com staff writers
Radiation oncology firm Elekta announced it has sold two Synergy radiotherapy systems to the Riverina Cancer Care Center in Wagga Wagga, New South Wales, Australia.
September 16, 2012
Nordion realigns into 2 business units
By AuntMinnie.com staff writers
Nordion is realigning to create two business units: Targeted Therapies and Specialty Isotopes. The Specialty Isotopes segment will include Sterilization Technologies and Medical Isotopes.
September 12, 2012
Elekta wins Brazilian install
By AuntMinnie.com staff writers
Radiation oncology firm Elekta announced it has won a contract with a Brazilian hospital for its therapy and planning systems.
September 11, 2012
Varian brings Unique linac to China
By AuntMinnie.com staff writers
Radiation therapy vendor Varian Medical Systems has received China State Food and Drug Administration (SFDA) clearance for its Unique medical linear accelerator.
September 10, 2012
Cranial irradiation decreases NSCLC metastases
By Cynthia E. Keen
Cranial irradiation of patients with stage III non-small cell lung cancer (NSCLC) significantly reduces the risk of developing brain metastases. However, it has no effect on survival, according to a presentation at the Chicago Multidisciplinary Symposium in Thoracic Oncology held September 6-8.
September 10, 2012
ASTRO asks CMS to halt planned payment cuts
By AuntMinnie.com staff writers
A letter to the U.S. Centers for Medicare and Medicaid Services (CMS) is the American Society for Radiation Oncology's (ASTRO) latest push in its campaign to stop proposed payment cuts of nearly $300 million scheduled to begin next near.
September 9, 2012
Meningioma patients report good QOL years after radiotherapy
By Cynthia E. Keen
A patient diagnosed with meningioma of the skull base can have several treatment options, all with known risks. Radiation therapy may be the more palatable option, maintaining or improving quality of life (QOL), according to a new study published in Radiotherapy and Oncology.
September 9, 2012
Outcomes improve for early-stage NSCLC patients
By Cynthia E. Keen
Outcomes have improved in patients with stage I non-small cell lung cancer (NSCLC) in the U.S. since 1999, with the improvement presumably coming from radiation therapy, according to a study presented at this week's Chicago Multidisciplinary Symposium in Thoracic Oncology.
September 6, 2012
Previous Page
Page 210 of 468
Next Page